Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (21-30 of 331) with videos related to

Pageof 34
Sort By:
Seminars in Thrombosis and Hemostasis|October 23, 2012
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR)Thomas J Moore, Charles L Bennett
Leukemia & Lymphoma|April 7, 2009
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberatingKenneth R Carson, Charles L Bennett
Cancer|December 13, 2005
Local perspective of the impact of the HIPAA privacy rule on researchMichael S Wolf, Charles L Bennett
JAMA Network Open|March 4, 2025
Valuing Clinical Strategies Immediately After FDA ApprovalCharles L Bennett, Kevin B Knopf
Urology|May 28, 2013
Editorial commentSandip M Prasad, Charles L Bennett
Seminars in Thrombosis and Hemostasis|November 7, 2012
Adverse effects of drugs on hemostasis and thrombosisHau C Kwaan, Charles L Bennett
Cancer Journal (Sudbury, Mass.)|September 26, 2025
Introduction to a Supplement From the Cancer Journal: The Journal of Principles and Practice of OncologyCharles L Bennett, Kevin B Knopf
JAMA Network Open|October 2, 2025
PARP Inhibitors in Metastatic Castrate-Resistant Prostate CancerCharles L Bennett, June M McKoy
Acta Radiologica (Stockholm, Sweden : 1987)|October 13, 2012
Six years afterHenrik S Thomsen, Charles L Bennett
Urology|November 12, 2022
EDITORIAL COMMENTKevin B Knopf, Charles L Bennett
Pageof 34

Showing results (21-30 of 331) with videos related to

Sort By:
Pageof 34
Seminars in Thrombosis and Hemostasis|October 23, 2012
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR)Thomas J Moore, Charles L Bennett
Leukemia & Lymphoma|April 7, 2009
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberatingKenneth R Carson, Charles L Bennett
Cancer|December 13, 2005
Local perspective of the impact of the HIPAA privacy rule on researchMichael S Wolf, Charles L Bennett
JAMA Network Open|March 4, 2025
Valuing Clinical Strategies Immediately After FDA ApprovalCharles L Bennett, Kevin B Knopf
Urology|May 28, 2013
Editorial commentSandip M Prasad, Charles L Bennett
Seminars in Thrombosis and Hemostasis|November 7, 2012
Adverse effects of drugs on hemostasis and thrombosisHau C Kwaan, Charles L Bennett
Cancer Journal (Sudbury, Mass.)|September 26, 2025
Introduction to a Supplement From the Cancer Journal: The Journal of Principles and Practice of OncologyCharles L Bennett, Kevin B Knopf
JAMA Network Open|October 2, 2025
PARP Inhibitors in Metastatic Castrate-Resistant Prostate CancerCharles L Bennett, June M McKoy
Acta Radiologica (Stockholm, Sweden : 1987)|October 13, 2012
Six years afterHenrik S Thomsen, Charles L Bennett
Urology|November 12, 2022
EDITORIAL COMMENTKevin B Knopf, Charles L Bennett
Pageof 34